Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Resource Fruit liquid orange
0913311E0BBABAA
|
Resource ready to serve discontinued juice | Ready to serve discontinued juice (0913311) | Nutrition and Blood | No data available |
|
Resource Fruit liquid pear & cherry
0913311E0BBACAA
|
Resource ready to serve discontinued juice | Ready to serve discontinued juice (0913311) | Nutrition and Blood | No data available |
|
Resource Fruit liquid raspberry & blackcurrant
0913311E0BBADAA
|
Resource ready to serve discontinued juice | Ready to serve discontinued juice (0913311) | Nutrition and Blood | No data available |
|
Resource Protein Extra liquid
090402000BBKQA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Resource Protein liquid
090402000BBQDA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Resource SeniorActiv liquid caramel toffee
090402000BBTLA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Resource SeniorActiv liquid creamy vanilla
090402000BBTMA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Resource SeniorActiv liquid strawberry biscuit
090402000BBTNA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Resource Shake liquid
090402000BBGMA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Resource Support drink
090402000BBQNA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Retacrit 1,000units/0.3ml inj pre-filled syringes
0901030Q0BBAAAA
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 2,000units/0.6ml inj pre-filled syringes
0901030Q0BBABAB
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 20,000units/0.5ml inj pre-filled syringes
0901030Q0BBAJAJ
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 3,000units/0.9ml inj pre-filled syringes
0901030Q0BBACAC
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 4,000units/0.4ml inj pre-filled syringes
0901030Q0BBADAD
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 40,000units/1ml inj pre-filled syringes
0901030Q0BBAIAI
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 5,000units/0.5ml inj pre-filled syringes
0901030Q0BBAEAE
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 6,000units/0.6ml inj pre-filled syringes
0901030Q0BBAFAF
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 8,000units/0.8ml inj pre-filled syringes
0901030Q0BBAGAG
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retenere Food Supplement tablets
0913472A0BCAAAB
|
Retenere tablets/capsules micronutrient supplement | Tabs/Caps OTC cond specific vitamin & mineral supp (0913472) | Nutrition and Blood | No data available |
|
Retinol 150,000units/ml oral drops
0906011D0AAAXAX
|
Vitamin A | Vitamin A | Nutrition and Blood | No data available |
|
Revolade 25mg tablets
0901040C0BBAAAA
|
Revolade | Eltrombopag | Nutrition and Blood | No data available |
|
Revolade 50mg tablets
0901040C0BBABAB
|
Revolade | Eltrombopag | Nutrition and Blood | No data available |
|
Revolade 75mg tablets
0901040C0BBACAC
|
Revolade | Eltrombopag | Nutrition and Blood | No data available |
|
RiboEss 100mg sustained release tablets
0906025P0BPACBM
|
RiboEss | Riboflavin | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.